Ph
O
R
HN
O
N
R1
R2
1a–f
+
R3NHNH2
EtOH / H
b)
a)
N
R3
Ph
Ph
N
HN
N
R2
HN
N
N
O
R3
R2
R
O
N
R1
R1
R
2a–h
1 a R = H, b–f R = Me; a, c–f R1 = Et, b R1 = Me; a, b, d R2 = OMe, c R2 = H, e R2= NMe2,
f R = Br; 2 a R = H, b–h R = Me; a, c–h R1 = Et, b R1 = Me, a, b, d–f R2 = OMe, c R2 = H,
g R2 = NMe2, h R2 = Br; a–c, f–h R3 = Ph, d R3 = H, e R3 = Et
5-[5-(4-Methoxyphenyl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl]-1,6-dimethyl-4-phenyl-3,4-dihydro-
2(1H)-pyrimidone (2b) was obtained in 32% yield; mp 243-245°C (EtOH). IR spectrum, ν, cm-1: 1502, 1596,
1
1675, 2916, 3076. H NMR spectrum, δ, ppm (J, Hz): 7.69 (1H, br. d, J = 3.2, NH); 7.15-7.40 (5H, m, ArH);
7.05 (2H, t, J = 7.6, ArH); 6.36-7.00 (7H, m, ArH); 5.37 (1H, d, J = 3.2, H-4); 5.21 (1H, dd, J1 = 11.2, J2 = 4.4,
CH); 3.72 (1H, dd, J1 = 16.8, J2 = 11.2, CH); 3.64 (3H, s, OCH3); 3.05 (3H, s, NCH3); 2.75 (1H, dd, J1 = 16.8,
J2 = 4.4, CH); 2.22 (3H, s, 6-CH3). Found, %: N 12.53. C28H28N4O2. Calculated, %: N 12.38.
1-Ethyl-5-(1,5-diphenyl-4,5-dihydro-1H-pyrazol-3-yl)-6-methyl-4-phenyl-3,4-dihydro-2(1H)-pyrimi-
done (2c) was obtained in 37% yield; mp 204-206°C (EtOH). IR spectrum, ν, cm-1: 1595, 1662, 3056, 3210,
1
3403. H NMR spectrum, δ, ppm (J, Hz): 7.60 (1H, br. d, J = 2.8, NH); 6.86-7.40 (12H, m, ArH); 6.79 (2H, t,
J = 7.8, ArH); 6.60 (1H, t, J = 7.4, ArH); 5.36 (1H, d, J = 2.8, H-4); 5.17-5.32 (1H, m, CH); 3.30-3.90 (3H, m,
CH3CH2 + CH); 2.80 (1H, dd, J1 = 16.6, J2 = 4.8, CH); 2.24 (3H, s, 6-CH3); 1.04 (3H, t, J = 7.0, CH3CH2).
Found, %: N 13.02. C28H28N4O. Calculated, %: N 12.83.
1-Ethyl-5-[5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-6-methyl-4-phenyl-3,4-dihydro-
2(1H)-pyrimidone (2d) was obtained in 29% yield; mp 157-159°C (EtOH). IR spectrum, ν, cm-1: 1682, 2923,
3230, 3290. 1H NMR spectrum, δ, ppm (J, Hz): 7.47 (1H, br. d, J = 2.8, N(3)H); 6.70-7.50 (6H, m, C6H5 + NH);
7.05 (2H, d, J = 8.6, ArH); 6.74 (2H, d, J = 8.6, ArH); 5.15 (1H, d, J = 2.8, H-4); 4.55 (1H, t, J = 9.4, CH); 3.68
(3H, s, OCH3); 3.60-3.90 (1H, m, CH); 3.00-3.60 (2H, m, CH2); 2.55 (1H, dd, J1 = 15.0, J2 = 9.4, CH); 2.16
(3H, s, 6-CH3); 0.99 (3H, t, J = 7.0, CH3CH2). Found, %: N 14.57. C23H26N4O2. Calculated, %: N 14.35.
1-Ethyl-5-[5-(1-ethyl-4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-6-methyl-4-phenyl-3,4-dihydro-
2(1H)-pyrimidone (2e) was obtained in 21% yield; mp 183-185°C (EtOH). IR spectrum, ν, cm-1: 1662, 2956,
3210. 1H NMR spectrum, δ, ppm (J, Hz): 7.54 (1H. br. d, J = 3.2, N(3)H); 7.10-7.40 (7H, m, ArH); 6.85 (2H, d,
J = 8.6, ArH); 5.14 (1H, d, J = 4.0, H-4); 3.71 (3H, s, OCH3); 3.60-4.20 (2H, m, CH2); 3.00-3.60 (3H, m,
H Alk); 2.40-2.90 (2H, m, H Alk); 2.17 (3H, s, 6-CH3); 1.00 (3H, t, J = 7.0, CH3CH2); 0.97 (3H, t, J = 7.0,
CH3CH2). Found, %: N 13.20. C25H30N4O2. Calculated, %: N 13.39.
1-Ethyl-5-[5-(4-methoxyphenyl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl]-6-methyl-4-phenyl-3,4-di-
hydro-2(1H)-pyrimidone (2f) was obtained in 43% yield; mp 194-195°C (EtOH); IR spectrum, ν, cm-1: 1596,
874